Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD (Non-alcoholic Fatty Liver Disease)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06220695
What this trial is testing

A Nutrigenetic Intervention in MASLD

Who this might be right for
NAFLDFatty Liver
Maastricht University 300
Not applicableStudy completedNCT03524365
What this trial is testing

Bariatric Surgery Versus Non-alcoholic Steato-hepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Catholic University of the Sacred Heart 288
Not applicableUnknownNCT03481465
What this trial is testing

Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis

Who this might be right for
SchizophreniaPsychosisMetabolic Syndrome
Fundación Marques de Valdecilla 200
Not applicableLooking for participantsNCT06566105
What this trial is testing

The Liver BIoBank Lombardia of Fatty Liver

Who this might be right for
NAFLDPrecision MedicineCardiovascular Diseases
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 2,500
Testing effectiveness (Phase 2)UnknownNCT05784779
What this trial is testing

Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD

Who this might be right for
NASHNAFLD
1Globe Biomedical Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT02421094
What this trial is testing

Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Galectin Therapeutics Inc. 30
Not applicableStudy completedNCT05712603
What this trial is testing

The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 655
Not applicableUnknownNCT02609243
What this trial is testing

Diabetes Nutrition Algorithm - Prediabetes

Who this might be right for
PrediabetesDiabetes Mellitus Type 2Obesity+2 more
German Institute of Human Nutrition 250
Large-scale testing (Phase 3)UnknownNCT05731596
What this trial is testing

Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Tanta University 46
Not applicableUnknownNCT05781568
What this trial is testing

Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)

Who this might be right for
HCCCirrhosis, LiverNAFLD+2 more
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 60
Early research (Phase 1)Study completedNCT05117489
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Corcept Therapeutics 70
Testing effectiveness (Phase 2)Study completedNCT04216589
What this trial is testing

Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

Who this might be right for
HIV InfectionsNon-Alcoholic Fatty Liver Disease
National Institute of Allergy and Infectious Diseases (NIAID) 51
Testing effectiveness (Phase 2)Study completedNCT02681055
What this trial is testing

Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects

Who this might be right for
Non-alcoholic SteatohepatitisHypertriglyceridemiaNon-alcoholic Fatty Liver Disease+1 more
MediciNova 19
Not applicableLooking for participantsNCT05697991
What this trial is testing

Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
King Saud University 1,000
Not applicableStudy completedNCT00930384
What this trial is testing

A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis

Who this might be right for
PsoriasisNonalcoholic Fatty Liver Disease
George Washington University 150
Large-scale testing (Phase 3)Looking for participantsNCT07265297
What this trial is testing

Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis

Who this might be right for
Steatohepatitis, Nonalcoholic
National Taiwan University Hospital 210
Testing effectiveness (Phase 2)Study completedNCT02283710
What this trial is testing

The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease

Who this might be right for
Fatty Liver
Tehran University of Medical Sciences 120
Post-approval studies (Phase 4)Study completedNCT00227110
What this trial is testing

Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
The University of Texas Health Science Center at San Antonio 55
Testing effectiveness (Phase 2)Study completedNCT01766713
What this trial is testing

Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
University of California, San Diego 50
Large-scale testing (Phase 3)Ended earlyNCT03028740
What this trial is testing

AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Tobira Therapeutics, Inc. 1,778
Next Page